This is unpublished
November 14, 2025
Nora Disis receives Champion Award
She has been selected by the Society for Immunotherapy of Cancer (SITC) as a 2025 Champion.
Scroll for more
Dr. Nora Disis, professor (Hematology and Oncology) and Director of the Cancer Vaccine Institute, has been selected by the Society for Immunotherapy of Cancer (SITC) as a 2025 Champion.
This special recognition, part of SITC’s 40th anniversary celebration, honors 40 individuals whose work has significantly advanced the society’s mission—including education, scientific exchange, global access, advocacy, and leadership development.
Dr. Disis’ pioneering contributions to cancer vaccines and immunotherapy and her unwavering commitment to collaboration and innovation have made a lasting impact on the field and on SITC’s growth.
Her leadership continues to inspire researchers, clinicians, and advocates working to transform cancer care.